Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis

Tissue Engineering - Part A

Volumn 16, Issue 10, 2010, Pages 3271-3284

  Ishida, Kazunari ^a   Matsumoto, Tomoyuki ^a   Sasaki, Ken ^a   Mifune, Yutaka ^a   Tei, Katsumasa ^a   Kubo, Seiji ^a   Matsushita, Takehiko ^a   Takayama, Koji ^a   Akisue, Toshihiro ^a   Tabata, Yasuhiko ^b   Kurosaka, Masahiro ^a   Kuroda, Ryosuke ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DEFECTS; DRUG DELIVERY; FLOW CYTOMETRY; POLYMERASE CHAIN REACTION; POLYMETHYL METHACRYLATES;

BLOOD FLOW; BONE DEVELOPMENT; BONE FORMATION; BONE REGENERATION; CATIONIZED; COMPUTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; FRACTURE HEALING; GELATIN HYDROGELS; GRANULOCYTE-COLONY STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; LOCAL ENVIRONMENTS; NEOVASCULARIZATION; OSTEOCALCIN; OSTEOGENESIS; REVASCULARIZATION; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; SEGMENTAL BONE DEFECT; THERAPEUTIC POTENTIALS; VASCULARIZATION;

BONE;

ORYCTOLAGUS CUNICULUS;

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE REGENERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RABBITS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957652725     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0268     Document Type: Article

References (59)

1. Schmitz, J.P., and Hollinger, J.O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res Apr;(205), 299, 1986.
2. Asselmeier, M.A., Caspari, R.B., and Bottenfield, S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 21, 170, 1993.
3. Tomford, W.W. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77, 1742, 1995.
4. Hollinger, J.O., Brekke, J., Gruskin, E., and Lee, D. Role of bone substitutes. Clin Orthop Relat Res Mar;(324), 55, 1996.
5. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4, 743, 2004.
6. Kraus, K.H., and Kirker-Head, C. Mesenchymal stem cells and bone regeneration. Vet Surg 35, 232, 2006.
7. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., and Yin, S. Osteogenic protein-1 (bone mor-phogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
8. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Fei-bel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Ruter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., and Wisniewski, T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
9. Eckardt, H., Ding, M., Lind, M., Hansen, E.S., Christensen, K.S., and Hvid, I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87, 1434, 2005.
10. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
11. Geiger, F., Bertram, H., Berger, I., Lorenz, H., Wall, O., Ec-khardt, C., Simank, H.G., and Richter, W. Vascular endo-thelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20, 2028, 2005.
12. Yamada, T., Kaneko, H., Iizuka, K., Matsubayashi, Y., Kokai, Y., and Fujimoto, J. Elevation of lymphocyte and hemato-poietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab Invest 74, 384, 1996.
13. Tamura, M., Hattori, K., Nomura, H., Oheda, M., Kubota, N., Imazeki, I., Ono, M., Ueyama, Y., Nagata, S., Shirafuji, N., et al. Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem Biophys Res Com-mun 142, 454, 1987.
14. Takano, H., Qin, Y., Hasegawa, H., Ueda, K., Niitsuma, Y., Ohtsuka, M., and Komuro, I. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med 84, 185, 2006.
15. Ohki, Y., Heissig, B., Sato, Y., Akiyama, H., Zhu, Z., Hicklin, D.J., Shimada, K., Ogawa, H., Daida, H., Hattori, K., and Ohsaka, A. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular en-dothelial growth factor from neutrophils. FASEB J 19, 2005, 2005.
16. Kuethe, F., Krack, A., Fritzenwanger, M., Herzau, M., Opfermann, T., Pachmann, K., Sayer, H.G., Werner, G.S., Gottschild, D., and Figulla, H.R. Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion. Pharmazie 61, 957, 2006.
17. Matsumoto, T., Kawamoto, A., Kuroda, R., Ishikawa, M., Mifune, Y., Iwasaki, H., Miwa, M., Horii, M., Hayashi, S., Oyamada, A., Nishimura, H., Murasawa, S., Doita, M., Kurosaka, M., and Asahara, T. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169, 1440, 2006.
18. Mifune, Y., Matsumoto, T., Kawamoto, A., Kuroda, R., Shoji, T., Iwasaki, H., Kwon, S.M., Miwa, M., Kurosaka, M., and Asahara, T. Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bios-caffold for modality of unhealing bone fracture. Stem Cells 26, 1395, 2008.
19. Fukunaka, Y., Iwanaga, K., Morimoto, K., Kakemi, M., and Tabata, Y. Controlled release of plasmid DNA from catio-nized gelatin hydrogels based on hydrogel degradation. J Control Release 80, 333, 2002.
20. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5, 127, 1999.
21. Yamamoto, M., Takahashi, Y., and Tabata, Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12, 1305, 2006.
22. Kokubo, S., Fujimoto, R., Yokota, S., Fukushima, S., Nozaki, K., Takahashi, K., and Miyata, K. Bone regeneration by re-combinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials 24, 1643, 2003.
23. Kushibiki, T., Tomoshige, R., Fukunaka, Y., Kakemi, M., and Tabata, Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release 90, 207, 2003.
24. Bertone, A.L., Pittman, D.D., Bouxsein, M.L., Li, J., Clancy, B., and Seeherman, H.J. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J Orthop Res 22, 1261, 2004.
25. Hokugo, A., Ozeki, M., Kawakami, O., Sugimoto, K., Mushimoto, K., Morita, S., and Tabata, Y. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11, 1224, 2005.
26. Hollinger, J.O., Schmitt, J.M., Buck, D.C., Shannon, R., Joh, S.P., Zegzula, H.D., and Wozney, J. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 43, 356, 1998.
27. Ford, J.L., Robinson, D.E., and Scammell, B.E. Endochondral ossification in fracture callus during long bone repair: the localisation of "cavity-lining cells" within the cartilage. J Orthop Res 22, 368, 2004.
28. Hofstaetter, J.G., Saad, F.A., Sunk, I.G., Bobacz, K., Friehs, I., and Glimcher, M.J. Age-dependent expression of VEGF isoforms and receptors in the rabbit anterior cruciate ligament. Biochim Biophys Acta 1770, 997, 2007.
29. Ishida, K., Kuroda, R., Miwa, M., Tabata, Y., Hokugo, A., Kawamoto, T., Sasaki, K., Doita, M., and Kurosaka, M. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 13, 1103, 2007.
30. Iwasaki, H., Kawamoto, A., Ishikawa, M., Oyamada, A., Nakamori, S., Nishimura, H., Sadamoto, K., Horii, M., Matsumoto, T., Murasawa, S., Shibata, T., Suehiro, S., and Asahara, T. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardi-omyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113, 1311, 2006.
31. Gomez-Ochoa, P., Miana-Mena, F.J., Munoz, M.J., Cativiela, E., and Gomez, F. An in vitro study of hematopoietic progenitor cells from peripheral blood of rabbits. Can J Vet Res 69, 309, 2005.
32. Kaigler, D., Wang, Z., Horger, K., Mooney, D.J., and Krebsbach, P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21, 735, 2006.
33. Welte, K., Bonilla, M.A., Gillio, A.P., Boone, T.C., Potter, G.K., Gabrilove, J.L., Moore, M.A., O'Reilly, R.J., and Souza, L.M. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophos-phamide-treated primates. J Exp Med 165, 941, 1987.
34. Demetri, G.D., and Griffin, J.D. Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791, 1991.
35. Inano, H., Kameyama, S., Yasui, S., and Nagai, A. Granulo-cyte colony-stimulating factor induces neutrophil sequestration in rabbit lungs. Am J Respir Cell Mol Biol 19, 167, 1998.
36. Ulich, T.R., del Castillo, J., and Souza, L. Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am J Pathol 133, 630, 1988.
37. Adachi, K., Suzuki, M., Sugimoto, T., Uetsuka, K., Naka-maya, H., and Doi, K. Effects of granulocyte colony-stimulating factor on the kinetics of inflammatory cells in the peripheral blood and pulmonary lesions during the development of bleomycin-induced lung injury in rats. Exp Tox-icol Pathol 55, 21, 2003.
38. Fukuhara, S., Tomita, S., Nakatani, T., Ohtsu, Y., Ishida, M., Yutani, C., and Kitamura, S. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 13, 741, 2004.
39. Sotnikova, N.V., Stavrova, L.A., Gur'antseva, L.A., Khrich-kova, T.Y., Fomina, T.I., Vetoshkina, N.V., Dubskaya, T.Y., Sergeeva, S.A., Epshtein, O.I., Ermolaeva, L.A., Dygai, A.M., and Gol'dberg, E.D. Mechanisms of the effects of granulo-cytic CSF on tissue reparation during chronic CCl4-induced damage to the liver. Bull Exp Biol Med 140, 644, 2005.
40. Solaroglu, I., Jadhav, V., and Zhang, J.H. Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 12, 712, 2007.
41. Yannaki, E., Athanasiou, E., Xagorari, A., Constantinou, V., Batsis, I., Kaloyannidis, P., Proya, E., Anagnostopoulos, A., and Fassas, A. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33, 108, 2005.
42. Bozlar, M., Aslan, B., Kalaci, A., Baktiroglu, L., Yanat, A.N., and Tasci, A. Effects of human granulocyte-colony stimulating factor on fracture healing in rats. Saudi Med J 26, 1250, 2005.
43. Kaygusuz, M.A., Turan, C.C., Aydin, N.E., Temel, I., Firat, S., Bulut, T., and Kuku, I. The effects of G-CSF and naproxen sodium on the serum TGF-beta1 level and fracture healing in rat tibias. Life Sci 80, 67, 2006.
44. Bolander, M.E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200, 165, 1992.
45. Pardanaud, L., Yassine, F., and Dieterlen-Lievre, F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105, 473, 1989.
46. Risau, W., Sariola, H., Zerwes, H.G., Sasse, J., Ekblom, P., Kemler, R., and Doetschman, T. Vasculogenesis and angio-genesis in embryonic-stem-cell- derived embryoid bodies. Development 102, 471, 1988.
47. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., and Isner, J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221, 1999.
48. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964, 1997.
49. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J.M., and Asahara, T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascu-larization. Nat Med 5, 434, 1999.
50. Kawamoto, A., Tkebuchava, T., Yamaguchi, J., Nishimura, H., Yoon, Y.S., Milliken, C., Uchida, S., Masuo, O., Iwaguro, H., Ma, H., Hanley, A., Silver, M., Kearney, M., Losordo, D.W., Isner, J.M., and Asahara, T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461, 2003.
51. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Leh-mann, R., Dobert, N., Grunwald, F., Aicher, A., Urbich, C., Martin, H., Hoelzer, D., Dimmeler, S., and Zeiher, A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009, 2002.
52. Britten, M.B., Zeiher, A.M., and Schachinger, V. Effects of cardiovascular risk factors on coronary artery remodeling in patients with mild atherosclerosis. Coron Artery Dis 14, 415, 2003.
53. Khosla, S., and Eghbali-Fatourechi, G.Z. Circulating cells with osteogenic potential. Ann N Y Acad Sci 1068, 489, 2006.
54. Eghbali-Fatourechi, G.Z., Lamsam, J., Fraser, D., Nagel, D., Riggs, B.L., and Khosla, S. Circulating osteoblast-lineage cells in humans. N Engl J Med 352, 1959, 2005.
55. Eghbali-Fatourechi, G.Z., Modder, U.I., Charatchar-oenwitthaya, N., Sanyal, A., Undale, A.H., Clowes, J.A., Tarara, J.E., and Khosla, S. Characterization of circulating osteoblast lineage cells in humans. Bone 40, 1370, 2007.
56. Laing, A.J., Dillon, J.P., Condon, E.T., Street, J.T., Wang, J.H., McGuinness, A.J., and Redmond, H.P. Mobilization of en-dothelial precursor cells: systemic vascular response to musculoskeletal trauma. J Orthop Res 25, 44, 2007.
57. Christopher, M.J., and Link, D.C. Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation. J Bone Miner Res 23, 1765, 2008.
58. Nakamura, A., Tanaka, S., Takayama, H., Sakamoto, M., Ishii, H., Kusano, M., Onizuka, Y., Ota, S., and Mitamura, K. A mesenteric liposarcoma with production of granulocyte colony-stimulating factor. Intern Med 37, 884, 1998.
59. Marui, T., Yamamoto, T., Akisue, T., Hitora, T., Yoshiya, S., and Kurosaka, M. Granulocyte colony-stimulating factor-producing undifferentiated sarcoma occurring in previously fractured femur. A case report and review of the literature. Arch Pathol Lab Med 127, e186, 2003.